Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Diabetes markedly increases the risk of coronary artery disease and death, but is underrecognised as a cardiovascular risk factor, despite the existence of effective treatments. Because patients with diabetes are at high risk for coronary disease, they have more to gain from prevention. There is evidence from clinical trials that select cardiovascular therapies may work better in diabetes, beyond their expected benefit, and may prevent diabetes itself.

Original publication




Journal article


Clin Med (Lond)

Publication Date





472 - 477


Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Clinical Trials as Topic, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Humans, Hypoglycemic Agents, Metformin, Risk Factors